netFormulary NHS
Nottinghamshire Area Prescribing Committee
Joint Formulary
 Search
 Results

Looking for Adalimumab found 24 matches

Formulary items 4 matches
   
Open monograph to display formulary status BNF Category
  Restricted Drug Adalimumab
(Gastroenterology)
Gastro-intestinal system - Cytokine inhibitors - 01.05.03
  Restricted Drug Adalimumab
(rheumatology)
Musculoskeletal and joint diseases - Drugs affecting the immune response - 10.01.03
  Restricted Drug Adalimumab
(Ophthalmology)
Eye - Other anti-inflammatory preparations - 11.04.02
  Restricted Drug Adalimumab
(Dermatology)
Skin - Drugs affecting the immune response - 13.05.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section Clinical Commissioning Policy: Adalimumab for Children with Severe Refractory Uveitis (10.01.03)
link in drug section NICE TA187: Crohn’s disease - infliximab and adalimumab  (01.05.03)
link in drug section NICE TA187: Crohns disease - infliximab & adalimumab (01.05.03)
link in drug section NICE TA187: Crohns disease - infliximab & adalimumab (01.05.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis  (01.05.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis  (01.05.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis  (01.05.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis (01.05.03)
link in drug section NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for JIA (10.01.03)
link in drug section NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (10.01.03)
link in drug section NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (10.01.03)
link in drug section NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (10.01.03)
link in subsection NICE TA375: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab & abatacept in RA (10.01.03)
link in drug section NICE TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa (13.05.03)
link in drug section NICE TA455:Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA455:Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA455:Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.01)
link in drug section NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.02)
link in subsection Psoriatic arthritis - etanercept, infliximab and adalimumab (NICE TA199) (10.01.03)


 

netFormulary